.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done
. Ed(S): Finke, James H.; Bukowski, Ronald M.
€ 196.75
FREE Delivery in Ireland
Description for Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done
hardcover. Details the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. This title reviews the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors. Editor(s): Finke, James H.; Bukowski, Ronald M. Series: Current Clinical Oncology. Num Pages: 403 pages, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 29. Weight in Grams: 846.
Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques ... Read more
Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques ... Read more
Product Details
Format
Hardback
Publication date
2003
Publisher
Humana Press United States
Number of pages
403
Condition
New
Series
Current Clinical Oncology
Number of Pages
386
Place of Publication
Totowa, NJ, United States
ISBN
9781588291837
SKU
V9781588291837
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done
"...good reading for all those interested in oncological immunotherapy." -Cancer Forum "State of the art and insightful...illuminates the possibilities for developing effective immunotherapies that can block the mechanisms by which tumors evade the immune system in different histologic types of tumors." - Tumori